Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:ATCCode |
N02BE51
|
| gptkbp:availableOn |
gptkb:tablet
capsule effervescent tablet |
| gptkbp:brand |
Kapake
Solpadeine Tylex |
| gptkbp:compatibleWith |
United States (as a named product)
|
| gptkbp:contains |
gptkb:paracetamol
gptkb:codeine |
| gptkbp:form |
oral
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cocodamol
|
| gptkbp:legalStatus |
controlled drug (UK, higher strengths)
|
| gptkbp:marketedIn |
gptkb:Ireland
gptkb:United_Kingdom |
| gptkbp:notRecommendedFor |
children under 12
people with liver disease |
| gptkbp:prescriptionStatus |
over-the-counter (UK, lower strengths)
prescription only (UK, higher strengths) |
| gptkbp:riskFactor |
overdose
respiratory depression (from codeine) liver damage (from paracetamol) |
| gptkbp:sideEffect |
nausea
constipation drowsiness addiction risk |
| gptkbp:usedFor |
pain relief
|
| gptkbp:bfsParent |
gptkb:Codeine
|
| gptkbp:bfsLayer |
6
|